Combating Bioequivalence Data Fraud: Indian CROs Face Mandatory Registration

Indian CROs Will Need To Register Their Business From 1 April

As Indian CROs are bracing for new registration mandates, an expert panel at the IGBA’s 3rd Bioequivalence conference discusses the implications of non-compliance in bioequivalence studies.

A hand manipulating data in a graph
(Shutterstock)

Contract research organizations based in India will be facing mandatory registration from 1 April in a bid to improve the country’s clinical research industry.

The registration portal was launched earlier in March, with the Central Drugs Standard Control Organization providing a registration process manual....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from IGBA

More from Products